[340 Pages Report] The global demand for 3D printed medical implants is expected to rise at a healthy CAGR of 12.5% to be valued at US$ 2,494.5 million by 2032, supported by the following:
| Attributes | Details |
|---|---|
| 3D Printed Medical Implants Market Size (2022) | US$ 680.9 million |
| 3D Printed Medical Implants Market Size (2032) | US$ 2,494.5 million |
| 3D Printed Medical Implants Market CAGR | 12.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The 3D printed medical implants market is driven by the surging prevalence of various medical issues. With the rising number of people facing orthopedic, cardiac, and dental diseases, the demand for 3D dental bridges, 3D dental crowns, shoulder implants, and 3D acetabular hip implants, among many other implants, is observing heightened demand.
In 2022, World Health Organization (WHO) reported that about 14% of the global adult population is estimated to be witnessing severe periodontal diseases, which results in infection and inflammation in the ligaments and bones that uphold the teeth. Similarly, the growing prevalence of other medical conditions is boosting the demand for 3D printed medical implants.
Regionally, North America is expected to contribute to the highest market share due to the rising number of product launches and the heightened presence of key regional players. Further, the market is also expected to be positively influenced by the presence of high-quality and widespread healthcare facilities, particularly hospitals and diagnostic imaging centers, and the surging infrastructure for the 3D printer in healthcare facilities.
Principal Consultant
The Asia Pacific market is expected to observe healthy growth due to ongoing market expansion by key market players in the region. For instance, in July 2018, Oxford Performance Materials Inc. (OPM), upon receiving accreditation as a foreign medical device producer by the Japanese Ministry of Health, Labour, and Welfare, partnered with JSR Corp. (JSR), a Tokyo-based materials provider, to form OPM Asia. The manufacturing of 3D printers of PEKK implants began in Japan, with products for sale in Asia in 2019.
The market is predicted to foster over the forecast period attributable to recent collaborations between the market players. For instance, in July 2022, Oxford Performance Materials announced an agreement with Fuse Medical, Inc. (Fuse), a producer and distributor of inventive medical devices, to construct new, premium-quality spinal, extremity and sports medicine implant product lines by using OPM’s patented OsteoFab® PEKK technology.
As per the 3D printed medical implants market study, 3D printing, also known as additive manufacturing, is a process by which a three-dimensional object is constructed from a digital model, layer by layer. Although it is still in its infancy, this technology holds great promise for a variety of medical implant applications.
Increased demand for medical implantation due to the prevalence of bone-dental problems, and strategic investments by key players are all factors propelling the 3D printed medical implants market.
There has been a huge increase in public and private funding to support various efforts in the 3D printing sector in recent years. In turn, the global demand for 3D printed medical implants is expected to expand during the forecast period as a result of these research and funding initiatives.
The demand for 3D printed medical implants is growing rapidly and addressing a significant unmet need. Training surgeons with computer simulations before actual operations can boost healthcare efficiency. Products in the global 3D printing medical implants market also aid in the reconstruction of lost facial features, tissue, and even limbs due to serious conditions like arthritis.
In addition, thanks to developments in technology like nanomaterials, clinicians can now construct accurate duplicates of individual anatomy, allowing them to expand their services naturally. As a result of the 3D printing technology and the virtual planning and supervision it provides, major surgeries like total joint replacement and heart replacement are now feasible.
There is optimism that the 3D printed medical implants market is likely to grow at a healthy rate over the next few years. Medical devices are being constructed using 3D printing technology, which is a form of additive manufacturing.
Medical device designers benefit from 3D printing's adaptability because it makes it simple to install new machinery, do away with the need for specific tools, or implement alterations. The result is anticipated to be a 1.3-fold increase in market demand for 3D printed medical implants over the forecast period.
After expanding at a CAGR of 15.9% between 2017 and 2021, Future Market Insights predicts the 3D printing medical devices market is likely to slow to a CAGR of 12.5% between 2022 and 2032.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In recent years, public and private funding for 3D printing projects have increased significantly. The development of 3D printing products and technologies are anticipated to be stimulated by such research and funding activities, which in turn is expected to drive the expansion of the 3D printing medical devices market.
The following are some recent advances that are shaping up the printed medical implants market. The top software platform for additive manufacturing processes is likely to be developed with USD 40 million that topology (US) raised in September 2020.
The The University of Huddersfield in the United Kingdom received USD 2.6 million (EUR 2.25 million) from Innovate UK in March 2019 to create a new generation of electron-beam additive manufacturing (EBAM) printers.
Without a properly trained workforce, additive manufacturing and 3D printing are forecasted to struggle to gain widespread acceptance. The rapid pace of evolution of the 3D printing medical devices market in terms of technology and materials has exacerbated the already severe shortage of personnel knowledgeable in 3D printing processes.
Additive manufacturing education options are limited, and it can be challenging to bridge the gap between classroom theory and real-world practice. In additive manufacturing, product quality can suffer from a lack of skilled workers due to a gap in knowledge about the design and manufacturing processes. Without this kind of labour force, the medical device industry would be unable to fully embrace 3D printing.
The market for medical devices made using 3D printing is largest in North America, where they account for 46.7% of the total. During the years 2022-2032, the regional demand for 3D printed medical implants is anticipated to grow at a CAGR of 14.3 per cent.
The rising prevalence of healthcare facilities like hospitals and diagnostic centres, as well as the rising prevalence of 3D printers in these settings, are driving the industry's expansion.
The market for medical devices made using 3D printing is largest in North America, where they account for 46.7% of the total. During the years 2022-2032, the regional demand for 3D printed medical implants is anticipated to grow at a CAGR of 14.3 percent.
The rising prevalence of healthcare facilities like hospitals and diagnostic centres, as well as the rising prevalence of 3D printers in these settings, are driving the industry's expansion.
With respective shares of 19.5% and 18.7%, East and South Asia are major contributors to the 3D printing medical devices market in the Asia-Pacific region. Together, they control 31.1% of the global demand for 3D printed medical implants.
However, it is predicted that the region is expected to be the fastest growing 3D printed medical implants market, expanding at a CAGR of 15.3 per cent over the forecast period. This is because there is a higher demand for healthcare overall, and medical device sales have been increasing rapidly.
It is also a prime location for medical device manufacturing and sourcing, so many companies in this industry are looking to set up shop there. In the years to come, this is likely to be a driving force in the 3D printed medical implants market.
To improve clinical workflow, the medical and dental industries have become increasingly digitised over the years. In the 3D printing medical implants market, digital dentistry and operations are replacing conventional surgical procedures. The term "direct digital manufacturing" refers to the process whereby a physical object is made from a digital design using computer-controlled procedures.
Owing to developments in 3D printing, direct digital manufacturing is quickly replacing more conventional methods of production. The time from design to production is shortened, the output is increased, and tooling costs are nullified, making it a compelling option.
Competition in the international demand for 3D printed medical implants is fierce because of the large number of local vendors. Key players engage in a wide range of promotional activities, including mergers and acquisitions, expansions, collaborations, and partnerships.
Top companies also use new product development as a means of increasing their consumer base and cementing their position as industry leaders. As a result of these efforts, cutting-edge 3D printed medical tools are now routinely used.
Cerhum SA, Oxford Performance Materials Inc., Straumann Group, MedShape, Inc., Renovis Surgical Technologies, Inc., BioArchitects, 3D Medical Manufacturing, Inc., EOS GmbH, Stratasys Ltd., and Emerging Implant Technologies GmbH among others
Some of the recent developments in the 3D Printed Medical Implants market are:
In March of 2021, Stratasys Ltd. unveiled the J5 DentaJet 3D Poly Jet printer for use in dental labs through their SLM Solutions partnership with Canwell Medical. Canwell Medical is expected to now be able to use SLM machines to create 3D printed surgical implant products thanks to this collaboration.
Canwell Medical is projected to receive an application and technical assistance, as well as research and development support, as it moves forward with serial production and product certification.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 12.5% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2016 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Material, Application, and Region. |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Cerhum SA; Oxford Performance Materials Inc.; Straumann Group; MedShape, Inc.; Renovis Surgical Technologies, Inc.; BioArchitects; 3D Medical Manufacturing, Inc.; EOS GmbH; Stratasys Ltd.; and Emerging Implant Technologies GmbH among others |
The 3D printed medical implants market is anticipated to generate a CAGR of 12.5% during the forecast period.
The lack of available specialized training in additive manufacturing has led to a shortage of skilled labor in the 3D printed medical implants market.
By 2032, the 3D printed medical implants market is likely to grow to a revenue of US$ 2,494.5 Mn.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Material
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Material, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Material, 2022-2032
5.3.1. Metals
5.3.2. Ceramics
5.3.3. Polymers
5.3.4. Composites
5.4. Y-o-Y Growth Trend Analysis By Material, 2017-2021
5.5. Absolute $ Opportunity Analysis By Material, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Hearing Aids
6.3.2. Dentistry
6.3.3. Orthopedic
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Material
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Material
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Material
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Material
9.3.3. By Application
9.4. Key Takeaways
10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Material
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Material
10.3.3. By Application
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. India
11.2.1.5. Malaysia
11.2.1.6. Singapore
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of APAC
11.2.2. By Material
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Material
11.3.3. By Application
11.4. Key Takeaways
12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Material
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Material
12.3.3. By Application
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Material
13.1.2.2. By Application
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Material
13.2.2.2. By Application
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Material
13.3.2.2. By Application
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Material
13.4.2.2. By Application
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Material
13.5.2.2. By Application
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Material
13.6.2.2. By Application
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Material
13.7.2.2. By Application
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Material
13.8.2.2. By Application
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Material
13.9.2.2. By Application
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Material
13.10.2.2. By Application
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Material
13.11.2.2. By Application
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Material
13.12.2.2. By Application
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Material
13.13.2.2. By Application
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Material
13.14.2.2. By Application
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Material
13.15.2.2. By Application
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Material
13.16.2.2. By Application
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Material
13.17.2.2. By Application
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Material
13.18.2.2. By Application
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Material
13.19.2.2. By Application
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Material
14.3.3. By Application
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Straumann Group
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. MedShape, Inc
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Renovis Surgical Technologies, Inc
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. BioArchitects
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. 3D Medical Manufacturing, Inc.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. EOS GmbH
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Stratasys Ltd.
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Emerging Implant Technologies GmbH
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Oxford Performance Materials Inc
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Dental Duty
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
3D Printed Medical Implants Market
